OXGENE是一家位于英国牛津的无锡高级治疗(无锡ATU)公司,为世界各地的细胞和基因治疗先驱提供技术、自动化平台和服务解决方案,使他们在提供突破性治疗的竞争中领先。
我们的发现技术帮助先驱者推进他们的CAR-T、CRISPR、衣壳或启动子发现计划。我们的生物制造解决方案进一步加快慢病毒、AAV或腺病毒载体疗法的开发和可扩展制造。
我们的开拓精神激励着我们;我们思想开放、合作、反应迅速、雄心勃勃。我们突破了可能性的界限,推动突破性疗法从实验室研究一直到临床生产。
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. Our discovery technologies help pioneers advance their CAR-T, CRISPR, capsid or promoter discovery programmes. Our biomanufacturing solutions further accelerate the development and scalable manufacture of lentiviral, AAV or adenoviral vector based therapeutics. Our pioneering spirit fuels us; we're open minded, collaborative, responsive and ambitious. We push the boundaries of possibility to drive breakthrough therapeutics from laboratory research all the way to clinical manufacture.